BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23111974)

  • 1. Relation of interatrial duration and p wave terminal force as a novel indicator of severe mitral regurgitation.
    Elbey MA; Oylumlu M; Akil A; Demirtas S; Ertas F; Erdogan E; Tasal A; Bacaksiz A; Simsek Z; Kaya H; Akyuz A
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1576-81. PubMed ID: 23111974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interatrial block and P-terminal force: a reflection of mitral stenosis severity on electrocardiography.
    Yuce M; Davutoglu V; Akkoyun C; Kizilkan N; Ercan S; Akcay M; Sari I
    J Heart Valve Dis; 2011 Nov; 20(6):619-23. PubMed ID: 22655490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of functional mitral regurgitation and anemia in patients with non-ischemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Kirma C; Kilicgedik A; Dundar C; Pala S; Cevik C; Guler A; Gurel E; Basaran Y
    Cardiol J; 2010; 17(3):274-80. PubMed ID: 20535718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leaflet remodelling in functional mitral valve regurgitation: characteristics, determinants, and relation to regurgitation severity.
    Debonnaire P; Al Amri I; Leong DP; Joyce E; Katsanos S; Kamperidis V; Schalij MJ; Bax JJ; Marsan NA; Delgado V
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):290-9. PubMed ID: 25368208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse.
    Cameli M; Lisi M; Righini FM; Massoni A; Natali BM; Focardi M; Tacchini D; Geyer A; Curci V; Di Tommaso C; Lisi G; Maccherini M; Chiavarelli M; Massetti M; Tanganelli P; Mondillo S
    Am J Cardiol; 2013 Feb; 111(4):595-601. PubMed ID: 23211360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation.
    Pizarro R; Bazzino OO; Oberti PF; Falconi M; Achilli F; Arias A; Krauss JG; Cagide AM
    J Am Coll Cardiol; 2009 Sep; 54(12):1099-106. PubMed ID: 19744620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of papillary muscle dyssynchrony in predicting the severity of functional mitral regurgitation in patients with non-ischaemic dilated cardiomyopathy: a two-dimensional speckle-tracking echocardiography study.
    Tigen K; Karaahmet T; Dundar C; Guler A; Cevik C; Basaran O; Kirma C; Basaran Y
    Eur J Echocardiogr; 2010 Sep; 11(8):671-6. PubMed ID: 20237053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation.
    Edwards NC; Moody WE; Yuan M; Weale P; Neal D; Townend JN; Steeds RP
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):946-53. PubMed ID: 25140067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension.
    Corciova FC; Corciova C; Georgescu CA; Enache M; Anghel D; Bartos O; Tinica G
    Heart Surg Forum; 2012 Jun; 15(3):E127-32. PubMed ID: 22698598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe mitral regurgitation-relations between magnetic resonance imaging, echocardiography and natriuretic peptides.
    Hellgren L; Landelius J; Stridsberg M; Kvidal P; Ståhle E; Bjerner T
    Scand Cardiovasc J; 2008 Feb; 42(1):48-55. PubMed ID: 17943627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: data from the Acorn trial.
    Park SM; Park SW; Casaclang-Verzosa G; Ommen SR; Pellikka PA; Miller FA; Sarano ME; Kubo SH; Oh JK
    Am Heart J; 2009 Apr; 157(4):762.e3-10. PubMed ID: 19332207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-parametric system for risk stratification in mitral regurgitation: A multi-task Gaussian prediction approach.
    Tse G; Zhou J; Lee S; Liu Y; Leung KSK; Lai RWC; Burtman A; Wilson C; Liu T; Li KHC; Lakhani I; Zhang Q
    Eur J Clin Invest; 2020 Nov; 50(11):e13321. PubMed ID: 32535888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic evaluation of percutaneous valve repair in patients with mitral regurgitation using the CARILLON system.
    Jerzykowska O; Kałmucki P; Wołoszyn M; Smuszkiewicz P; Firek L; Siminiak T
    Kardiol Pol; 2010 Jan; 68(1):57-63. PubMed ID: 20131189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenting area reflects disease severity and prognosis in patients with non-ischaemic dilated cardiomyopathy and functional mitral regurgitation.
    Karaca O; Avci A; Guler GB; Alizade E; Guler E; Gecmen C; Emiroglu Y; Esen O; Esen AM
    Eur J Heart Fail; 2011 Mar; 13(3):284-91. PubMed ID: 21106544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of left atrial volume in asymptomatic organic mitral regurgitation.
    Arias A; Pizarro R; Oberti P; Falconi M; Lucas L; Sosa F; Funes D; Cagide A
    J Am Soc Echocardiogr; 2013 Jul; 26(7):699-705. PubMed ID: 23623592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial volume: predictor of atrial fibrillation in patients with degenerative mitral regurgitation.
    Tanabe K; Yamaguchi K; Tani T; Yagi T; Katayama M; Tamita K; Kinoshita M; Kaji S; Yamamuro A; Morioka S; Okada Y; Kihara Y
    J Heart Valve Dis; 2007 Jan; 16(1):8-12. PubMed ID: 17315377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atrioventricular valve insufficiency and atrial geometry in orthotopic heart transplantation].
    De Simone R; Lange R; Sack FU; Mehmanesh H; Hagl S
    Cardiologia; 1994 May; 39(5):325-34. PubMed ID: 8087814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial function as a guide to timing of intervention in mitral valve prolapse with mitral regurgitation.
    Ring L; Rana BS; Wells FC; Kydd AC; Dutka DP
    JACC Cardiovasc Imaging; 2014 Mar; 7(3):225-32. PubMed ID: 24529886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of color flow mapping and Doppler echocardiography in the quantification of mitral regurgitation in patients with mitral valve prolapse or rheumatic heart disease.
    Pinheiro AC; Mancuso FJ; Hemerly DF; Kiyose AT; Campos O; de Andrade JL; de Paola AA; de Camargo Carvalho AC; Moises VA
    J Am Soc Echocardiogr; 2007 Oct; 20(10):1141-8. PubMed ID: 17588714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.